Shopping Cart
Remove All
Your shopping cart is currently empty
Z-VEID-FMK is a selective and cell-permeable caspase-6 peptide inhibitor that irreversibly covalently binds to the active site of the enzyme, thereby inhibiting apoptosis and DNA breakage.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $106 | In Stock | In Stock | |
| 5 mg | $282 | In Stock | In Stock | |
| 10 mg | $468 | - | In Stock | |
| 25 mg | $747 | - | In Stock |
| Description | Z-VEID-FMK is a selective and cell-permeable caspase-6 peptide inhibitor that irreversibly covalently binds to the active site of the enzyme, thereby inhibiting apoptosis and DNA breakage. |
| In vitro | Pretreatment of HepG2 by Z-VEID-FMK (50 μM, 1 h) reduced drug-induced caspase-6 activity in HepG2 cells by 53%, reduced apoptosis by 58%, and reduced DNA breakage by 44%. [1] |
| Synonyms | Z-VE(OMe)ID(OMe)-FMK |
| Molecular Weight | 652.71 |
| Formula | C31H45FN4O10 |
| Cas No. | 210344-96-0 |
| Smiles | [C@@H](NC([C@@H](NC([C@@H](NC(OCC1=CC=CC=C1)=O)[C@H](C)C)=O)CCC(OC)=O)=O)(C(N[C@@H](CC(OC)=O)C(CF)=O)=O)[C@H](CC)C |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Sequence | Cbz-DL-Val-DL-Glu(OMe)-DL-xiIle-DL-Asp(OMe)-CH2F |
| Sequence Short | VXXX |
| Storage | keep away from moisture,store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (306.41 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (7.66 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.